• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于肌肉萎缩症流行病学的系统评价与荟萃分析

A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies.

作者信息

Mah Jean K, Korngut Lawrence, Fiest Kirsten M, Dykeman Jonathan, Day Lundy J, Pringsheim Tamara, Jette Nathalie

机构信息

1Department of Clinical Neurosciences,University of Calgary,Calgary,Alberta,Canada.

出版信息

Can J Neurol Sci. 2016 Jan;43(1):163-77. doi: 10.1017/cjn.2015.311.

DOI:10.1017/cjn.2015.311
PMID:26786644
Abstract

BACKGROUND

The muscular dystrophies are a heterogeneous group of genetic muscle diseases with variable distribution of weakness and mode of inheritance.

METHODS

We previously performed a systematic review of worldwide population-based studies on Duchenne and Becker muscular dystrophies; the current study focused on the epidemiology of other muscular dystrophies using Medline and EMBASE databases. Two reviewers independently reviewed all abstracts, full-text articles, and abstracted data from 1985 to 2011. Pooling of prevalence estimates was performed using random-effect models.

RESULTS

A total of 1104 abstracts and 167 full-text articles were reviewed. Thirty-one studies met all eligibility criteria and were included in the final analysis. The overall pooled prevalence of combined muscular dystrophies was 16.14 (confidence interval [CI], 11.21-23.23) per 100,000. The prevalence estimates per 100,000 were 8.26 (CI, 4.99-13.68) for myotonic dystrophy, 3.95 (CI, 2.89-5.40) for facioscapulohumeral dystrophy, 1.63 (CI, 0.94-2.81) for limb girdle muscular dystrophy, and 0.99 (CI, 0.62-1.57) for congenital muscular dystrophies.

CONCLUSIONS

The studies differed widely in their approaches to case ascertainment, and substantial gaps remain in the global estimates of many other types of muscular dystrophies. Additional epidemiological studies using standardized diagnostic criteria as well as multiple sources of case ascertainment will help address the economic impact and health care burden of muscular dystrophies worldwide.

摘要

背景

肌营养不良症是一组异质性的遗传性肌肉疾病,肌无力分布和遗传方式各不相同。

方法

我们之前对全球范围内基于人群的杜氏和贝克肌营养不良症研究进行了系统评价;本研究利用Medline和EMBASE数据库,聚焦于其他肌营养不良症的流行病学。两名评价者独立评价了1985年至2011年期间所有的摘要、全文文章以及提取的数据。采用随机效应模型对患病率估计值进行汇总。

结果

共检索了1104篇摘要和167篇全文文章。31项研究符合所有纳入标准并纳入最终分析。合并肌营养不良症的总体汇总患病率为每10万人16.14(置信区间[CI],11.21 - 23.23)。每10万人的患病率估计值分别为:强直性肌营养不良症8.26(CI,4.99 - 13.68),面肩肱型肌营养不良症3.95(CI,2.89 - 5.40),肢带型肌营养不良症1.63(CI,0.94 - 2.81),先天性肌营养不良症0.99(CI,0.62 - 1.57)。

结论

这些研究在病例确定方法上差异很大,许多其他类型肌营养不良症的全球估计仍存在很大差距。采用标准化诊断标准以及多种病例确定来源的额外流行病学研究将有助于解决全球肌营养不良症的经济影响和医疗负担问题。

相似文献

1
A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies.关于肌肉萎缩症流行病学的系统评价与荟萃分析
Can J Neurol Sci. 2016 Jan;43(1):163-77. doi: 10.1017/cjn.2015.311.
2
Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis.全球杜氏肌营养不良症和贝克肌营养不良症的患病率:系统评价和荟萃分析。
J Orthop Surg Res. 2022 Feb 15;17(1):96. doi: 10.1186/s13018-022-02996-8.
3
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
4
A systematic review of risk factors associated with muscular dystrophies.肌营养不良症相关风险因素的系统评价。
Neurotoxicology. 2017 Jul;61:55-62. doi: 10.1016/j.neuro.2016.03.007. Epub 2016 Mar 24.
5
Drug treatment for facioscapulohumeral muscular dystrophy.面肩肱型肌营养不良症的药物治疗
Cochrane Database Syst Rev. 2004;2004(2):CD002276. doi: 10.1002/14651858.CD002276.pub2.
6
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
7
Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline.抗氧化剂预防杜氏肌营养不良症和进行性呼吸功能下降患者的呼吸功能下降。
Cochrane Database Syst Rev. 2021 Dec 1;12(12):CD013720. doi: 10.1002/14651858.CD013720.pub3.
8
Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline.抗氧化剂预防杜氏肌营养不良和进行性呼吸功能下降患者的呼吸功能下降。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013720. doi: 10.1002/14651858.CD013720.pub2.
9
Rehabilitation interventions for foot drop in neuromuscular disease.神经肌肉疾病中足下垂的康复干预措施。
Cochrane Database Syst Rev. 2009 Jul 8(3):CD003908. doi: 10.1002/14651858.CD003908.pub3.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.

引用本文的文献

1
Integrative Approaches to Myopathies and Muscular Dystrophies: Molecular Mechanisms, Diagnostics, and Future Therapies.肌病和肌肉萎缩症的综合治疗方法:分子机制、诊断及未来疗法
Int J Mol Sci. 2025 Aug 18;26(16):7972. doi: 10.3390/ijms26167972.
2
DUX4 at 25: how it emerged from "junk DNA" to become the cause of facioscapulohumeral muscular dystrophy.25岁的DUX4:它如何从“垃圾DNA”中脱颖而出,成为面肩肱型肌营养不良症的病因。
Skelet Muscle. 2025 Aug 25;15(1):24. doi: 10.1186/s13395-025-00388-0.
3
Assessing the socio-economic burden of inherited and inflammatory neuromuscular diseases (BIND study): a study protocol.
评估遗传性和炎性神经肌肉疾病的社会经济负担(BIND研究):一项研究方案。
Orphanet J Rare Dis. 2025 Aug 6;20(1):404. doi: 10.1186/s13023-025-03904-z.
4
Outcomes of an oral motor and swallowing rehabilitation program in patients with congenital myopathies.先天性肌病患者口腔运动与吞咽康复计划的效果
Codas. 2025 Jul 7;37(4):e20240294. doi: 10.1590/2317-1782/e20240294en. eCollection 2025.
5
Isolated Right Atrial Enhancement with Atrial Standstill: An Uncommon Presentation of Emery-Dreifuss Muscular Dystrophy.孤立性右心房增强伴心房静止:埃默里-德赖富斯肌营养不良症的罕见表现
Indian J Radiol Imaging. 2024 Dec 17;35(3):463-465. doi: 10.1055/s-0044-1800882. eCollection 2025 Jul.
6
Interests and Experiences of Young Adults with Muscular Dystrophy in Receiving Genetic Information.患有肌肉萎缩症的年轻人获取遗传信息的兴趣和经历。
J Child Neurol. 2025 Sep;40(8):641-650. doi: 10.1177/08830738251330413. Epub 2025 Apr 17.
7
Comparative Analysis of Splicing Alterations in Three Muscular Dystrophies.三种肌肉萎缩症中剪接改变的比较分析
Biomedicines. 2025 Mar 1;13(3):606. doi: 10.3390/biomedicines13030606.
8
Antisense oligonucleotide-mediated exon 27 skipping restores dysferlin function in dysferlinopathy patient-derived muscle cells.反义寡核苷酸介导的外显子27跳跃可恢复肌营养不良蛋白病患者来源的肌肉细胞中的dysferlin功能。
Mol Ther Nucleic Acids. 2024 Dec 21;36(1):102443. doi: 10.1016/j.omtn.2024.102443. eCollection 2025 Mar 11.
9
Limb-Girdle Muscular Dystrophies (LGMD): Clinical features, diagnosis and genetic variability through next generation sequencing.肢带型肌营养不良症(LGMD):临床特征、诊断及通过下一代测序技术分析的遗传变异性
Glob Med Genet. 2024 Dec 16;12(1):100035. doi: 10.1016/j.gmg.2024.100035. eCollection 2025 Mar.
10
Delivery of genetic medicines for muscular dystrophies.用于治疗肌肉萎缩症的基因药物递送
Cell Rep Med. 2025 Jan 21;6(1):101885. doi: 10.1016/j.xcrm.2024.101885. Epub 2025 Jan 6.